Literature DB >> 30753822

UTX Mutations in Human Cancer.

Lu Wang1, Ali Shilatifard2.   

Abstract

Ubiquitously transcribed tetratricopeptide repeat on chromosome X (UTX, encoded by KDM6A) is a histone demethylase that targets di- and tri-methylated histone H3 lysine 27 (H3K27). UTX function has been linked to homeotic gene expression, embryonic development, and cellular reprogramming. UTX and its protein interactors within the COMPASS family, including the MLL3 and MLL4 lysine methyltransferases, are frequently mutated in multiple human cancers; however, the molecular basis of how these mutations contribute to oncogenesis remains unclear. Here, we discuss catalytic-dependent and -independent functions of UTX and its partners MLL3 and MLL4 as part of the COMPASS family during development and in oncogenesis.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  UTX; cancer; chromatin; gene expression; transcription

Mesh:

Substances:

Year:  2019        PMID: 30753822      PMCID: PMC6589339          DOI: 10.1016/j.ccell.2019.01.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  83 in total

Review 1.  H3K27 demethylases, at long last.

Authors:  Tomek Swigut; Joanna Wysocka
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

2.  UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity.

Authors:  Chaochen Wang; Ji-Eun Lee; Young-Wook Cho; Ying Xiao; Qihuang Jin; Chengyu Liu; Kai Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

3.  The H3K27me3 demethylase dUTX is a suppressor of Notch- and Rb-dependent tumors in Drosophila.

Authors:  Hans-Martin Herz; Laurence D Madden; Zhihong Chen; Clare Bolduc; Eugene Buff; Ravi Gupta; Ramana Davuluri; Ali Shilatifard; Iswar K Hariharan; Andreas Bergmann
Journal:  Mol Cell Biol       Date:  2010-03-08       Impact factor: 4.272

4.  Comprehensive Characterization of Cancer Driver Genes and Mutations.

Authors:  Matthew H Bailey; Collin Tokheim; Eduard Porta-Pardo; Sohini Sengupta; Denis Bertrand; Amila Weerasinghe; Antonio Colaprico; Michael C Wendl; Jaegil Kim; Brendan Reardon; Patrick Kwok-Shing Ng; Kang Jin Jeong; Song Cao; Zixing Wang; Jianjiong Gao; Qingsong Gao; Fang Wang; Eric Minwei Liu; Loris Mularoni; Carlota Rubio-Perez; Niranjan Nagarajan; Isidro Cortés-Ciriano; Daniel Cui Zhou; Wen-Wei Liang; Julian M Hess; Venkata D Yellapantula; David Tamborero; Abel Gonzalez-Perez; Chayaporn Suphavilai; Jia Yu Ko; Ekta Khurana; Peter J Park; Eliezer M Van Allen; Han Liang; Michael S Lawrence; Adam Godzik; Nuria Lopez-Bigas; Josh Stuart; David Wheeler; Gad Getz; Ken Chen; Alexander J Lazar; Gordon B Mills; Rachel Karchin; Li Ding
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

Review 5.  Enhancer Logic and Mechanics in Development and Disease.

Authors:  Ryan Rickels; Ali Shilatifard
Journal:  Trends Cell Biol       Date:  2018-05-11       Impact factor: 20.808

6.  UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor.

Authors:  G Xie; X Liu; Y Zhang; W Li; S Liu; Z Chen; B Xu; J Yang; L He; Z Zhang; T Jin; X Yi; L Sun; Y Shang; J Liang
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

7.  UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1.

Authors:  Hee-Joo Choi; Ji-Hye Park; Mikyung Park; Hee-Young Won; Hyeong-Seok Joo; Chang Hoon Lee; Jeong-Yeon Lee; Gu Kong
Journal:  EMBO Rep       Date:  2015-08-24       Impact factor: 8.807

8.  Role of UTX in retinoic acid receptor-mediated gene regulation in leukemia.

Authors:  Luciana Rocha-Viegas; Raffaella Villa; Arantxa Gutierrez; Oihana Iriondo; Ramin Shiekhattar; Luciano Di Croce
Journal:  Mol Cell Biol       Date:  2014-07-28       Impact factor: 4.272

9.  Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.

Authors:  Kristel M Dorighi; Tomek Swigut; Telmo Henriques; Natarajan V Bhanu; Benjamin S Scruggs; Nataliya Nady; Christopher D Still; Benjamin A Garcia; Karen Adelman; Joanna Wysocka
Journal:  Mol Cell       Date:  2017-05-05       Impact factor: 17.970

10.  The C. elegans H3K27 demethylase UTX-1 is essential for normal development, independent of its enzymatic activity.

Authors:  Julien Vandamme; Gaëlle Lettier; Simone Sidoli; Elia Di Schiavi; Ole Nørregaard Jensen; Anna Elisabetta Salcini
Journal:  PLoS Genet       Date:  2012-05-03       Impact factor: 5.917

View more
  47 in total

Review 1.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

2.  The role of histone modifications in leukemogenesis.

Authors:  Noah W Birch; Ali Shilatifard
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

Review 3.  The Unexpected Noncatalytic Roles of Histone Modifiers in Development and Disease.

Authors:  Yann Aubert; Shaun Egolf; Brian C Capell
Journal:  Trends Genet       Date:  2019-07-10       Impact factor: 11.639

Review 4.  X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

Authors:  Rossella Tricarico; Emmanuelle Nicolas; Michael J Hall; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2020-07-30       Impact factor: 12.531

5.  Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.

Authors:  Jiaqing Yi; Xuanming Shi; Zhenyu Xuan; Jiang Wu
Journal:  Cancer Lett       Date:  2020-11-27       Impact factor: 8.679

6.  Significance of KDM6A mutation in bladder cancer immune escape.

Authors:  Xingxing Chen; Xuehua Lin; Guofu Pang; Jian Deng; Qun Xie; Zhengrong Zhang
Journal:  BMC Cancer       Date:  2021-05-29       Impact factor: 4.430

7.  The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.

Authors:  Beat Bornhauser; Gunnar Cario; Anna Rinaldi; Thomas Risch; Virginia Rodriguez Martinez; Moritz Schütte; Hans-Jörg Warnatz; Nastassja Scheidegger; Paulina Mirkowska; Martina Temperli; Claudia Möller; Angela Schumich; Michael Dworzak; Andishe Attarbaschi; Monika Brüggemann; Mathias Ritgen; Ester Mejstrikova; Andreas Hofmann; Barbara Buldini; Pamela Scarparo; Giuseppe Basso; Oscar Maglia; Giuseppe Gaipa; Tessa-Lara Skoblyn; Geertruij Te Kronnie; Elena Vendramini; Renate Panzer-Grümayer; Malwine Jeanette Barz; Blerim Marovca; Mathias Hauri-Hohl; Felix Niggli; Cornelia Eckert; Martin Schrappe; Martin Stanulla; Martin Zimmermann; Bernd Wollscheid; Marie-Laure Yaspo; Jean-Pierre Bourquin
Journal:  Blood Adv       Date:  2020-09-08

8.  PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer.

Authors:  Zibo Zhao; Aileen P Szczepanski; Natsumi Tsuboyama; Hiam Abdala-Valencia; Young Ah Goo; Benjamin D Singer; Elizabeth T Bartom; Feng Yue; Lu Wang
Journal:  Cancer Res       Date:  2021-08-02       Impact factor: 12.701

9.  Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy.

Authors:  Rumei Luan; Geng Tian; Hong Zhang; Xiaolei Shi; Jicui Li; Rui Zhang; Xuehong Lu
Journal:  J Nephrol       Date:  2021-07-22       Impact factor: 3.902

10.  UTX maintains the functional integrity of the murine hematopoietic system by globally regulating aging-associated genes.

Authors:  Yasuyuki Sera; Yuichiro Nakata; Takeshi Ueda; Norimasa Yamasaki; Shuhei Koide; Hiroshi Kobayashi; Ken-Ichiro Ikeda; Kohei Kobatake; Masayuki Iwasaki; Hideaki Oda; Linda Wolff; Akinori Kanai; Akiko Nagamachi; Toshiya Inaba; Yusuke Sotomaru; Tatsuo Ichinohe; Miho Koizumi; Yoshihiko Miyakawa; Zen-Ichiro Honda; Atsushi Iwama; Toshio Suda; Keiyo Takubo; Hiroaki Honda
Journal:  Blood       Date:  2021-02-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.